CAESAREA, Israel — Mazor Robotics Ltd. (NASDAQCM:MZOR; TASE:MZOR), the developer of Renaissance?, an innovative surgical guidance system and its complementary products, announced that it has received an order for a Renaissance system from Transmedic Pte Ltd., its distribution partner in Southeast Asia. The purchase of the system by Transmedic is another step in Mazors’ footprint expansion and momentum throughout the Asia Pacific region.
Renaissance? is transforming spine surgery from freehand procedures to highly-accurate, state-of-the-art procedures that may reduce fluoroscopy—even for minimally-invasive surgery (MIS), scoliosis, and other complex spinal deformity cases.
Mazor is targeting the Asia-Pacific region as a prime market following the U.S. market, and established distribution agreements in China, Japan and Australia, with systems already in clinical use in Taiwan, Viet Nam and India. “Asia Pacific represents a significant growth opportunity for Mazor,” commented Ori Hadomi, chief executive officer. “We are very pleased with our recent success in the Asia Pacific market, both at the clinical utilization level as well as at the expansion of our install base. I believe these developments continue to validate our business and sales model in the international markets, particularly in Asia Pacific.”
Transmedic Pte Ltd. was founded in 1980 and is headquartered in Singapore. Transmedic represents a wide range of medical device manufacturers and its reputation has been built upon its success of collaborating with surgical robotic companies in the Asia Pacific markets.Air Jordan 1 Shoes